Cargando…

A randomised controlled trial of bumetanide in the treatment of autism in children

Gamma aminobutyric acid (GABA)-mediated synapses and the oscillations they orchestrate are altered in autism. GABA-acting benzodiazepines exert in some patients with autism paradoxical effects, raising the possibility that like in epilepsies, GABA excites neurons because of elevated intracellular co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lemonnier, E, Degrez, C, Phelep, M, Tyzio, R, Josse, F, Grandgeorge, M, Hadjikhani, N, Ben-Ari, Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565189/ https://www.ncbi.nlm.nih.gov/pubmed/23233021 http://dx.doi.org/10.1038/tp.2012.124

Ejemplares similares

Bumetanide for autism: more eye contact, less amygdala activation
por: Hadjikhani, Nouchine, et al.
Publicado: (2018)

Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders
por: Lemonnier, E, et al.
Publicado: (2017)

Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders
por: Lemonnier, E, et al.
Publicado: (2017)

Failure of the Nemo Trial: Bumetanide Is a Promising Agent to Treat Many Brain Disorders but Not Newborn Seizures
por: Ben-Ari, Yehezkel, et al.
Publicado: (2016)

Bumetanide for autism: Open‐label trial in six children
por: Fernell, Elisabeth, et al.
Publicado: (2021)

A Wholistic View of How Bumetanide Attenuates Autism Spectrum Disorders
por: Delpire, Eric, et al.
Publicado: (2022)

Treatment Effect of Bumetanide in Children With Autism Spectrum Disorder: A Systematic Review and Meta-Analysis
por: Wang, Tiantian, et al.
Publicado: (2021)

The immuno-behavioural covariation associated with the treatment response to bumetanide in young children with autism spectrum disorder
por: Li, Qingyang, et al.
Publicado: (2022)

Bumetanide Therapeutic Effect in Children and Adolescents With Autism Spectrum Disorder: A Review Study
por: Mollajani, Raheleh, et al.
Publicado: (2019)

Environmental Factors Influence Language Development in Children with Autism Spectrum Disorders
por: Grandgeorge, Marine, et al.
Publicado: (2009)

The GABA Polarity Shift and Bumetanide Treatment: Making Sense Requires Unbiased and Undogmatic Analysis
por: Ben-Ari, Yehezkel, et al.
Publicado: (2022)

Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)
por: Crutel, Véronique, et al.
Publicado: (2020)

Successive clinical application of vitamin D and bumetanide in children with autism spectrum disorder: A case report
por: Feng, Jun-Yan, et al.
Publicado: (2020)

Correction to: Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)
por: Crutel, Véronique, et al.
Publicado: (2021)

Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA/glutamate ratios
por: Zhang, Lingli, et al.
Publicado: (2020)

Nanoformulated Bumetanide Ameliorates Social Deficiency in BTBR Mice Model of Autism Spectrum Disorder
por: Lv, Hui, et al.
Publicado: (2022)

Does Pet Arrival Trigger Prosocial Behaviors in Individuals with Autism?
por: Grandgeorge, Marine, et al.
Publicado: (2012)

Bumetanide for Irritability in Children With Sensory Processing Problems Across Neurodevelopmental Disorders: A Pilot Randomized Controlled Trial
por: van Andel, Dorinde M., et al.
Publicado: (2022)

Correction: Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA/glutamate ratios
por: Zhang, Lingli, et al.
Publicado: (2020)

Bumetanide: Metabolic alkalosis: case report
Publicado: (2021)

Atypical Color Preference in Children with Autism Spectrum Disorder
por: Grandgeorge, Marine, et al.
Publicado: (2016)

Bumetanide Exposure Association with Alzheimer’s Disease Risk
por: Graber-Naidich, Anna, et al.
Publicado: (2023)

Evaluation of bumetanide as a potential therapeutic agent for Alzheimer’s disease
por: Boyarko, Ben, et al.
Publicado: (2023)

Off-Label Use of Bumetanide for Brain Disorders: An Overview
por: Kharod, Shivani C., et al.
Publicado: (2019)

Bumetanide for neonatal seizures: No light in the pharmacokinetic/dynamic tunnel
por: Kaila, Kai, et al.
Publicado: (2022)

Failure of bumetanide to improve outcome after intracerebral hemorrhage in rat
por: Wilkinson, Cassandra M., et al.
Publicado: (2019)

Bumetanide As a Candidate Treatment for Behavioral Problems in Tuberous Sclerosis Complex
por: Vlaskamp, Chantal, et al.
Publicado: (2017)

It’s All in the Eyes: Subcortical and Cortical Activation during Grotesqueness Perception in Autism
por: Zürcher, Nicole R., et al.
Publicado: (2013)

A retrospective evaluation of the efficacy of intravenous bumetanide and comparison of potency with furosemide
por: Nappi, Jean M.
Publicado: (2013)

Bumetanide Prevents Brain Trauma-Induced Depressive-Like Behavior
por: Goubert, Emmanuelle, et al.
Publicado: (2019)

Albumin human/bumetanide: Osmotic demyelination syndrome: case report
Publicado: (2020)

Perception of Social Cues of Danger in Autism Spectrum Disorders
por: Zürcher, Nicole R., et al.
Publicado: (2013)

Simple Shapes Elicit Different Emotional Responses in Children with Autism Spectrum Disorder and Neurotypical Children and Adults
por: Belin, Laurine, et al.
Publicado: (2017)

Bumetanide Enhances Phenobarbital Efficacy in a Rat Model of Hypoxic Neonatal Seizures
por: Cleary, Ryan T., et al.
Publicado: (2013)

The NKCC1 antagonist bumetanide mitigates interneuronopathy associated with ethanol exposure in utero
por: Skorput, Alexander GJ, et al.
Publicado: (2019)

Longitudinal Effects of Bumetanide on Neuro-Cognitive Functioning in Drug-Resistant Epilepsy
por: Gharaylou, Zeinab, et al.
Publicado: (2019)

Bumetanide Suppression of Angiogenesis in a Rat Model of Oxygen-Induced Retinopathy
por: Guzel, Sibel, et al.
Publicado: (2020)

Analgesic Effect of Bumetanide on Neuropathic Pain in Patients With Spinal Cord Injury
por: Nasirinezhad, Farinaz, et al.
Publicado: (2021)

Bumetanide treatment during early development rescues maternal separation-induced susceptibility to stress
por: Hu, Die, et al.
Publicado: (2017)

Randomised controlled trial of simvastatin treatment for autism in young children with neurofibromatosis type 1 (SANTA)
por: Stivaros, Stavros, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6gls03ljs04nvtgr35bd39evbu